Jiangsu Shenji Biotechnology Co., Ltd.

Shenji Biotech was established in 2018 and focuses on providing customers with overall solutions for upstream raw materials in the field of life sciences. The core members of the company are from the Ph.D. team in chemical biology of Nanjing University. The chief scientist is Academician Chen Hongyuan. He has a strong technical background in chemical biology and has been committed to the research, development and industrialization of life science raw materials for many years. It now has an antibody discovery platform, an mRNA stock solution preparation platform, an mRNA-LNP preparation process platform, an oligonucleotide preparation platform, an enzyme directed evolution platform and other technologies. Driven by this, it has three major product segments: cell gene therapy raw materials, gene nucleic acid drug raw materials, and IVD raw materials. The company has been selected to cultivate unicorn enterprises in Nanjing and has received multiple rounds of financing worth hundreds of millions of yuan.